Application of percutaneous acupoint electrical stimulation in clipping craniotomy for aneurysm

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052353

Enrollment

Unknown

Registered

2021-10-24

Start date

2021-10-10

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

the TEAS group:"HANS" transcutaneous acupoint electrical stimulator

Control group: " Placebo-type HANS" transcutaneous acupoint electrical stimulator

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 40-70 years old; 2. ASA classification I-III; 3.Hunt grades I-III 4. Clinical informed consent for this study has been signed.

Exclusion criteria

Exclusion criteria: 1. Refuse to participate in this research; 2. Participated in other clinical studies; 3. Potential medical problems with transcutaneous electrical acupoint stimulation (TEAS): for example, those with pacemakers or metal implants or allergic to surface electrodes; 4. Mental illness; 5. History of alcohol, drug dependence or drug use; 6. Recent or routine acupuncture treatment history; 7. Severe heart, liver and kidney insufficiency.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Heart rate;Intraoperative remifentanil dosage;	—

Secondary

Measure	Time frame
beta-endorphin;S 100ß;Neuron specific enolase;Malondialdehyde;Superoxide Dismutase;	—

Countries

China

Contacts

Public ContactWang Lifeng

The First Affiliated Hospital of Gannan Medical College

wwwanglifeng@126.com+86 135 7671 5202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026